Pseudofolliculitis

  • 1  Garcia‐Zuazaga J. Pseudofolliculitis barbae. Review and update on new treatment modalities. Military Med 2003;168:561–4.
  • 2  Alexander AM. Pseudofolliculitis diathesis. Arch Dermatol 1974;109:729–30. Cross Ref link Pubmed link
  • 3  Dilaimy M. Pseudofolliculitis of the legs. Arch Dermatol 1976;112:507–8. Cross Ref link Pubmed link
  • 4  Khanna N, Chandramohan K, Khaitan BK, et al. Post waxing folliculitis: a clinicopathological evaluation. Int J Dermatol 2014;53:849–54. . Cross Ref link Pubmed link
  • 5  White SW, Rodman OG. Pseudofolliculitis vibrissa. Arch Dermatol 1981;117:368–9. Cross Ref link Pubmed link
  • 6  Liew HM, Morris‐Jones R, Diaz‐Cano S, et al. Pseudofolliculitis barbae induced by oral minoxidil. Clin Exp Derm 2012;37(7):800–1. Cross Ref link Pubmed link
  • 7  Daniel A, Gustafson CJ, Zupkosky, PJ, et al. Shave frequency and regimen variation effects on the management of pseudofolliculitis barbae. J Drugs Dermatol 2013;12(4):410–18. Pubmed link
  • 8  Alexander AM. Evaluation of a foil‐guarded shaver in the management of pseudofolliculitis barbae. Cutis 1981;27:534–42. Pubmed link
  • 9  Xia Y, Cho S, Howard RS, et al. Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: a randomized, double‐blinded, placebo‐controlled trial. J Am Acad Dermatol 2012;76(4):694–9. Cross Ref link

Folliculitis keloidalis

  • 10  Salami T, Omeife H, Samuel S. Prevalence of acne keloidalis nuchae in Nigerians. Int J Dermatol 2007;46:482. Cross Ref link Pubmed link
  • 11  Vasily DB, Breen PC, Miller OF. Acne keloidalis nuchae: report and treatment of a severe case. J Dermatol Surg Oncol 1979;5:228–30. Cross Ref link Pubmed link
  • 12  George AO, Akanji AO, Nduka EU, et al. Clinical, biochemical and morphologic features of acne keloidalis in a black population. Int J Dermatol 1993;32:714–16. Cross Ref link Pubmed link
  • 13  Khumalo NP, Jessop S, Gumedze J, et al. Hairdressing is associated with scalp disease in African schoolchildren. Br J Dermatol 2007;157:106–10. Cross Ref link Pubmed link
  • 14  Sperling L, Homoky C, Pratt L, et al. Acne keloidalis is a form of primary scarring alopecia. Arch Dermatol 2000;136:479–84. Pubmed link
  • 15  Esmat SM, Abdel RM, Abu OM, et al. The efficacy of laser‐assisted hair removal in the treatment of acne keloidalis nuchae; a pilot study. Eur J Dermatol 2012;22(5):645–50. Pubmed link

Necrotizing lymphocytic folliculitis of the scalp margin

  • 16  Kossard S, Collins A, McCrossin I. Necrotizing lymphocytic folliculitis: the early lesion of acne necrotica (varioliformis) J Am Acad Dermatol 1987;16:1007–14. Cross Ref link Pubmed link
  • 17  Stritzler C, Friedman R, Loveman A. Acne necrotica: relation to acne necrotica miliaris and response to penicillin and other antibiotics. Arch Dermatol Syphil 1951;64:464–9. Cross Ref link
  • 18  Zirn JR, Scott RA, Hambrick GW. Chronic acneiform eruption with crateriform scars. Acne necrotica (varioliformis) (necrotizing lymphocytic folliculitis). Arch Dermatol 1996;132:1367–70. Cross Ref link Pubmed link
  • 19  Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol 2005;53:1–37. Cross Ref link Pubmed link

Scalp folliculitis

  • 20  Hersle K, Mobacken H, Möller A. Chronic non‐scarring folliculitis of the scalp. Acta Dermatovenereol 1979;59:249–53.
  • 21  Montgomery H. Acne necrotica miliaris of the scalp. Arch Dermatol Syphilol 1937:36:40. Cross Ref link
  • 22  Maibach H. Scalp pustules due to Corynebacterium acnes. Arch Dermatol 1967;96(4):453–55. Cross Ref link Pubmed link

Actinic folliculitis

  • 23  Beukers SM, Van Doorn MBA, van Santen MM, Starink TM. Actinic folliculitis, a rare sunlight‐induced dermatosis. Ned Tijdschr Dermatol Venereol 2010;20:122–5.
  • 24  Veysey EC, George S. Actinic folliculitis. Clin Exp Dermatol 2005;30:659–61. Cross Ref link Pubmed link
  • 25  LaBerge L, Glassman S, Kanigsberg N. Actinic superficial folliculitis in a 29 year old man. J Cut Med Surg 2012;16:191–3.
  • 26  Verbov J. Actinic folliculitis. Br J Dermatol 1985;113:630–1. Cross Ref link Pubmed link
  • 27  Nieboer C. Actinic superficial folliculitis; a new entity? Br J Dermatol 1985;112:603–6. Cross Ref link Pubmed link
  • 28  Norris PG, Hawk JL. Actinic folliculitis – response to isotretinoin. Clin Exp Dermatol 1989;14:69–71. Cross Ref link Pubmed link

Disseminate and recurrent infundibulofolliculitis

  • 29  Owen WR, Wood C. Disseminate and recurrent infundibulofolliculitis. Arch Dermatol 1979;115:174–5. Cross Ref link Pubmed link
  • 30  Hinds GA, Heald PW. A case of disseminate and recurrent infundibulofolliculitis responsive to treatment with topical steroids. Dermatol Online J 2008;14(11):11. Pubmed link
  • 31  Ravikumar BC, Balachandran C, Shenoi SD, Sabitha L, Ramnarayan K. Disseminate and recurrent infundibulofolliculitis: response to psoralen plus UVA therapy. Int J Dermatol 1999;38:75–6. Cross Ref link Pubmed link
  • 32  Aroni K, Grapsa A, Agapitos E. Disseminate and recurrent infundibulofolliculitis: response to isotretinoin. Drugs Dermatol 2004;3:434–5.

Eosinophilic pustular folliculitis

  • 33  Nervi SJ, Schwartz RA, Dmochowski M. Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol 2006;55:285–9. Cross Ref link Pubmed link
  • 34  Ofuji S. Eosinophilic pustular folliculitis. Dermatologica 1987;174:53–6. Cross Ref link Pubmed link
  • 35  Lee WJ, Won KH, Won CH et al. Facial and extrafacial eosinophilic pustular folliculitis: a clinical and histopathological comparative study. Br J Dermatol 2014;170:1173–6. Cross Ref link Pubmed link
  • 36  Takematsu H, Tagami H. Eosinophilic pustular folliculitis. Studies on possible chemotactic factors involved in the formation of pustules. Br J Dermatol 1986;114:209–15. Cross Ref link Pubmed link
  • 37  Mabuchi T, Matsuyama T, Ozawa A. Eosinophilic pustular folliculitis associated with pregnancy. J Dermatol 2011;38:1191–3. Cross Ref link Pubmed link
  • 38  Kus S, Candan I, Ince U, et al. Eosinophilic pustular folliculitis (Ofuji's disease) exacerbated with pregnancies. J Eur Acad Dermatol Venereol 2006;20(10):1347–8. Cross Ref link Pubmed link
  • 39  Gutierrez HI, Carrillo MJ, Pestana S, et al. Ofuji's disease and pregnancy. A report of a case. Ginecol Obstet Mex 2006;74(3):158–63. Pubmed link
  • 40  Katoh M, Nomura T, Miyachi Y, et al. Eosinophilic pustular folliculitis: a review of the Japanese published works. J Dermatol 2013;40:15–20. Cross Ref link Pubmed link
  • 41  Rajendran PM, Dolev JC, Heaphy MR, Maurer T. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol 2005;141:1227–31. Cross Ref link Pubmed link
  • 42  Lankerani L, Thompson R. Eosinophilic pustular folliculitis: case report and review of the literature. Cutis 2010;86:190–4. Pubmed link
  • 43  Nunzi E, Parodi A, Rebora A. Ofuji's disease: a follow‐up. J Am Acad Dermatol 1986;15:107–8. Cross Ref link Pubmed link
  • 44  Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis. Am J Clin Dermatol 2004;5:189–97. Cross Ref link Pubmed link
  • 45  Soeprono FF, Schinella RA. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1986;14:1020–2. Cross Ref link Pubmed link
  • 46  Rho N‐K, Kim B‐J. Eosinophilic pustular folliculitis: successful treatment with topical pimecrolimus. Clin Exp Dermatol 2006;32:108–9.
  • 47  Malanin G, Helander I. Eosinophilic pustular folliculitis (Ofuji's disease): response to dapsone but not to isotretinoin therapy. J Am Acad Dermatol 1989;20:1121. Cross Ref link Pubmed link
  • 48  Steffen C. Eosinophilic pustular folliculitis (Ofuji's disease) with response to dapsone therapy. Arch Dermatol 1985;121:921–3. Cross Ref link Pubmed link
  • 49  Satoh T, Shimura C, Miyagishi C, et al. Indomethacin‐induced reduction in CRTH2 in Eosinophilic pustular folliculitis (Ofuji's disease): a proposed mechanism of action. Acta Dermatol Venereol 2010;90:18–22. Cross Ref link
  • 50  Buchness MR, Lim HW, Hatcher VA, et al. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome: treatment with ultraviolet B phototherapy. N Engl J Med 1988;318:1183–6. Cross Ref link Pubmed link

Infantile eosinophilic pustular folliculitis

  • 51  Lucky AW, Esterly NB, Heskel N, et al. Eosinophilic pustular folliculitis in infancy. Pediatr Dermatol 1984;1:202–6. Cross Ref link Pubmed link
  • 52  Taïeb A. Infantile eosinophilic pustular “folliculitis” in infancy: a nonfollicular disease. Pediatr Dermatol 1994;11:186.
  • 53  Buckley DE, Munn SE, Higgins EM. Neonatal eosinophilic pustular folliculitis. Clin Exp Dermatol 2001;26:251–5. Cross Ref link Pubmed link
  • 54  Hernández‐Martín Á, Nuño‐González A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol 2013;68:150–5. Cross Ref link Pubmed link
  • 55  Ramdial PK, Morar N, Dlova NC, Aboobaker J. HIV‐associated eosinophilic folliculitis in an infant. Am J Dermatopathol 1999;21:241–6. Cross Ref link Pubmed link
  • 56  Boone M, Dangoisse C, André J, Sass U, Song M, Ledoux M. Eosinophilic pustular folliculitis in three atopic children with hypersensitivity to Dermatophagoides pteronyssinus. Dermatology 1995;190:164–8. Cross Ref link Pubmed link
  • 57  Alonso‐Castro L, Pérez‐García B, González‐García C, Jaén‐Olasolo P. Eosinophilic pustular folliculitis in infancy: report of a new case. Dermatol Online J 2012;18:10.
  • 58  Taieb A, Bassan‐Andrieu L, Maleville J. Eosinophilic pustulosis of the scalp in childhood. J Am Acad Dermatol 1992;27:55–60. Cross Ref link Pubmed link
  • 59  Garcia‐Patos V, Pujol RM, Moragas JM. Infantile eosinophilic pustular folliculitis. Dermatology 1994;189(2):133–8.

Heterotopic sebaceous glands (Fordyce spots)

  • 60  Flinck A, Paludan A, Matsson L, Holm AK, Axelsson I. Oral findings in a group of newborn Swedish children. Int J Paediatr Dent 1994;4:67–73. Cross Ref link Pubmed link
  • 61  Vieira‐Andrade G, Martins‐Júnior PA, Corrêa‐Faria P, et al. Oral mucosal conditions in preschool children of low socioeconomic status: prevalence and determinant factors. Eur J Pediatr 2013;172:675–81. Cross Ref link Pubmed link
  • 62  Gorsky M, Buchner A, Fundoianu‐Dayan D, Cohen C. Fordyce's granules in the oral mucosa of adult Israeli Jews. Community Dent Oral Epidemiol 1986;14:231–2. Cross Ref link Pubmed link
  • 63  Michajłowski I, Sobjanek M, Michajłowski J, Włodarkiewicz A, Matuszewski M. Normal variants in patients consulted in the dermatology clinic for lesions of the male external genitalia. Cent European J Urol 2012;65:17–20. Cross Ref link Pubmed link
  • 64  Lynch PJ, Margesson LJ. Skin‐colored and red papules and nodules. In: Black M, Ambros‐Rudolph C, Edwards L, Lynch P, eds. Obstetric and Gynecologic Dermatology, 3rd edn. London: Mosby Elsevier, 2008:195–215. Cross Ref link
  • 65  Monteil RA. Fordyce's spots: disease, heterotopia or adenoma? Histological and ultrastructural study. J Biol Buccale 1981;9:109–28. Pubmed link
  • 66  Nordstrom KM, McGinley KJ, Lessin SR, Leyden JJ. Neutral lipid composition of Fordyce's granules. Br J Dermatol 1989;121:669–70. Cross Ref link Pubmed link
  • 67  Hyman AB, Brownstein MC. Tyson's “glands”: ectopic sebaceous glands and papillomatosis penis. Arch Dermatol 1969;99:31–6. Cross Ref link Pubmed link
  • 68  Errichetti E, Piccirillo A, Viola L, Ricciuti F, Ricciuti F. Areolar sebaceous hyperplasia associated with oral and genital Fordyce spots. J Dermatol 2013;40(8):670. Cross Ref link Pubmed link
  • 69  Lee JH, Lee JH, Kwon NH, et al. Clinicopathologic manifestations of patients with Fordyce's spots. Ann Dermatol 2012;24:103–6. Cross Ref link Pubmed link

Sebaceous gland hyperplasia

  • 70  Salim A, Reece SM, Smith AG, et al. Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. J Am Acad Dermatol 2006;55:878–81. Cross Ref link Pubmed link
  • 71  De Berker DAR, Taylor AE, Quinn AG, et al. Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes? J Am Acad Dermatol 1996;35:696–9. Cross Ref link Pubmed link
  • 72  Kumar P, Barton SP, Marks R. Tissue measurements in senile sebaceous gland hyperplasia. Br J Dermatol 1988;118:397–402. Cross Ref link Pubmed link
  • 73  Grimalt R, Ferrando J, Mascaro JM. Premature familial sebaceous hyperplasia: successful response to oral isotretinoin in three patients. J Am Acad Dermatol 1997;37:996–8. Cross Ref link Pubmed link
  • 74  Ahassi D, Gonzalez E, Anderson RR, et al. Elucidating the pulsed‐dye laser treatment of sebaceous hyperplasia in vivo with real‐time confocal scanning laser microscopy. J Am Acad Dermatol 2000;43:49–53. Cross Ref link Pubmed link
  • 75  No D, McClaren M, Chotzen V. Sebaceous hyperplasia treated with a 1450 nm diode laser. Dermatolog Surg 2004;30:383–4.
  • 76  Gollnick H, Orfanos CE. Front facial picture of a lady with familial nevoid sebaceous hyperplasia before and after treatment with isotretinoin. In: Wilkinson DS, Mascaro JM, Orfanos CE, eds. Clinical Dermatology. The CMD Case Collection. Stuttgart: Schattauer, 1987:350–2.
  • 77  Zouboulis CC, Rabe T. [Hormonal antiandrogens in acne treatment.] J Dtsch Dermatol Ges 2010 Mar;8 Suppl. 1:S60–74. Cross Ref link Pubmed link
  • 78  Richey DF. Aminolevulinic acid photodynamic therapy for sebaceous gland hyperplasia. Dermatol Clin 2007;25:59–65. Cross Ref link Pubmed link